Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

4.720

+0.020 (0.43%)

At close: Apr 9, 2026, 4:00 PM EDT

4.570

-0.150 (-3.18%)

After-hours: Apr 9, 2026, 4:21 PM EDT

Neuphoria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	22.17	14.21	12.61	12.1	23.15	21.37
Cash & Short-Term Investments	22.17	14.21	12.61	12.1	23.15	21.37
Cash Growth	410.30%	12.71%	4.17%	-47.72%	8.34%	576.52%
Other Receivables	1.11	0.01	0.13	0.43	-	-
Total Trade Receivables	1.11	0.01	0.13	0.43	-	-
Other Current Assets	0.11	0.82	0.46	0.8	-	-
Total Current Assets	23.39	15.04	13.19	13.33	28.84	23.19
Net Property, Plant & Equipment	-	0.11	0.22	0.33	0.47	0.65
Other Intangible Assets	4.47	4.8	5.47	6.13	-	-
Goodwill	8.74	8.64	8.69	8.69	8.88	9.3
Other Long-Term Assets	-	-	0.08	0.08	-	-
Total Assets	36.6	28.59	27.65	28.56	45.05	40.69
Accounts Payable	0.52	1.15	2.24	1.44	-	-
Accrued Expenses	2.07	2.95	1.46	1.19	-	-
Current Portion of Leases	-	0.12	0.12	0.11	0.11	0.13
Total Current Liabilities	2.59	4.22	3.83	2.74	2.31	1.77
Long-Term Leases	-	-	0.12	0.24	0.37	0.52
Other Long-Term Liabilities	4.31	5.37	6.21	3.57	3.1	2.7
Total Long-Term Liabilities	4.31	5.37	6.33	3.81	3.47	3.22
Total Liabilities	6.9	9.59	10.16	6.55	5.79	5
Common Stock	0	0	0	-	150.15	142.61
Additional Paid-in Capital	218.32	200.19	198.48	187.55	-	-
Accumulated Other Comprehensive Income	-2.23	-2.85	-3.01	-3.06	-	-
Retained Earnings	-186.39	-178.35	-177.98	-162.48	-119.54	-
Shareholders' Equity	29.7	19	17.49	22.01	39.26	35.69
Total Liabilities & Equity	36.6	28.59	27.65	28.56	45.05	40.69
Total Debt	-	0.12	0.24	0.35	0.48	0.65
Net Cash (Debt)	22.17	14.09	12.37	11.75	22.67	20.72
Net Cash Growth	57.30%	13.95%	5.27%	-48.18%	9.43%	693.39%
Net Cash Per Share	8.53	8.69	14.86	17.28	36.18	57.37
Book Value	29.7	19	17.49	22.01	39.26	35.69
Book Value Per Share	11.42	11.71	21.02	32.37	62.65	98.83
Tangible Book Value	16.49	5.56	3.33	7.19	30.38	26.39
Tangible Book Value Per Share	6.34	3.43	4.00	10.57	48.48	73.08

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q